MicroCare Acquires Certol International: Expands Products and Services

This acquisition is aligned with the MicroCare strategic goals and priorities, namely, to fuel growth through the delivery of innovative, value-added solutions and services into the global critical cleaning industry.
Certol International

MicroCare, LLC a global supplier of critical cleaning fluids and materials used in the electronics, medical device manufacturing, fiber optic and metal finishing markets announced today that it has acquired Certol International, a Denver, Colorado based manufacturer of specialty cleaning and disinfecting products to the medical, dental, and consumer marketplaces.

“We are very excited to announce this acquisition.  Certol has a 40-year history of providing EPA registered high performance surface disinfectants and specialty cleaners engineered for use.

in dental offices, medical offices, and hospital settings. Certol also manufactures specialty products used in industrial, marine and consumer cleaning applications,” said Tom Tattersall, Chief Executive Officer at MicroCare.

“We believe that the Certol product lines, customer relationships, and centralized U.S. location will reinforce our position as a leading supplier to the industries we serve, and will allow us to more efficiently deliver an expanded range of complementary solutions to our customers.  With this acquisition, MicroCare will continue to be well-situated to capitalize on the many emerging trends in the dental and medical markets.  We view this important acquisition as an excellent step to position the business for continued growth as we work with customers to solve their cleaning and disinfecting challenges.”

Certol International

This acquisition is aligned with the MicroCare strategic goals and priorities, namely, to fuel growth through the delivery of innovative, value-added solutions and services into the global critical cleaning industry.  The Certol leading product and development initiatives will amplify the already strong programs in the MicroCare pipeline and will enable continued focus on high growth segments, such as automotive, medical, electronics and fiber optic communications.

More

Artificial Intelligence Tools Make Education Materials More Patient Friendly

“Our study shows that widely used large language models have the potential to transform patient education materials into more readable content, which is essential for patient empowerment and better health outcomes,” said Study senior author Jonah Feldman, MD, medical director of transformation and informatics at NYU Langone.

CorWave Completes 6-Month In Vivo Study for Clinical Trials Initiation

In vivo studies demonstrated the pump’s successful operation for a period of up to six months. Additionally, nine chronic ovine implants were conducted for 60 days with no device failure or sign of thrombosis at explant. These significant milestones mark the final stage of CorWave’s preclinical development, paving the way for its First-In-Human study.